# Surveillance of Emerging Pathogens to Ensure Blood Supply Safety

> **NCT06462677** · — · WITHDRAWN · sponsor: **Canadian Blood Services**

## Conditions studied

- Babesioses, Human

## Interventions

- **DIAGNOSTIC_TEST:** Babesia NAT

## Key facts

- **NCT ID:** NCT06462677
- **Lead sponsor:** Canadian Blood Services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-02
- **Primary completion:** 2024-10-26
- **Final completion:** 2024-10-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The kits were FDA and Health Canada approved and therefore the clinical trial is no longer needed.
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06462677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06462677, "Surveillance of Emerging Pathogens to Ensure Blood Supply Safety". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06462677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*